It is used in the treatment of the following cancers: * Colorectal cancer (either as neoadjuvant therapy with radiation, adjuvant therapy or for metastatic cases) * Breast cancer (metastatic or as monotherapy/combotherapy; this is licensed as a second-line treatment in the UK) * Gastric cancer (off-label in the US; this is a licensed indication in the UK) * Oesophageal cancer (off-label in the US)
Capecitabine
Oxaliplatin
Gemcitabine
Lipoplatin
Ifosfamide
Paclitaxel
Carboplatin
Topotecan